Why Illumina Jumped 9.8% in November

Shares of the genomic sequencing specialist Illumina (NASDAQ: ILMN) rose nearly 10% in November, according to data from S&P Global Market Intelligence. However, there wasn't any company-specific news that can justify the move. Shareholders can likely chalk up the jump to continued enthusiasm for the company's breakout year

Image source: Getty Images.

While there wasn't any big news released during the month, the company did have a few positive announcements to make, including:

Continue reading


Source: Fool.com